BALTIMORE, Md.--DNA Bactofection, a novel technology for introducing genes into cells using live, attenuated invasive bacterial vectors, has been licensed to Microscience Ltd. by the University System ...
LONDON - Microscience Ltd. is being acquired by U.S. company Emergent BioSolutions Inc. in an all-paper deal that values the vaccine specialist at £40 million (US$73.1 million), roughly £5 million ...
The University of Maryland Biotechnology Institute announced Friday that it has licensed to Microscience Ltd. a technology delivers DNA into cells. The licensing agreement allows United Kingdom-based ...
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...
A British company developing a vaccine for "Delhi belly" hopes to raise £40m next month when it becomes the latest British biotechnology firm to brave flotation. Microscience, with several drugs in ...
Microscience, the biotechnology company developing a vaccine against the most common cause of traveller's diarrhoea or "Delhi belly", is planning to float on Aim for about £100m. The company has ...
Microscience, the vaccines developer, pulled its £140m stock market flotation yesterday, blaming poor market demand for its shares. It announced plans to float on the Alternative Investment Market in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results